This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Erythema elevatum dilutinum

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • rare localised cutaneous vasculitis in adults
  • idiopathic but may occasionaly occur in hepatitis, HIV or haematological malignancy (1)
    • other possible associations include (2) previous infection particularly by streptococcus or it can be a manifestation of occult neoplasia, including myeloma, myelodysplasia, or acute myelogenous leukaemia, and nonneoplastic disorders such as inflammatory bowel disease, relapsing polychondritis, and rheumatoid arthritis
    • there is no association with systemic vasculitis, and autoantibodies are not usually detected
  • red-purple plaques occur on the back of hands and joints; these plaques gradually harden and become yellow-brown
  • histology - leukocytoclasis with fibrosis and granuloma formation
    • even when the clinical course is chronic, the histological picture is acute (2) Microscopic features include angiocentric neutrophils with some leucocytoclasis, but fibrin is scanty
      • infiltrate is often mixed with some lipid-containing histiocytes
      • laminated angiocentric fibrosis again may be present.
  • treatment - dapsone treatment (1)

Reference:

  • (1) Dermatology in Practice (2003), 11(4), 14-18.
  • (2) Davies DJ. Small vessel vasculitis. Cardiovascular Pathology 2005; 14 (6): 335-346.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.